|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Trevigen
|
|
gptkbp:awards
|
Innovation Award 2019
Excellence in Research 2021
Best Biotech Company 2020
|
|
gptkbp:certification
|
gptkb:standard
gptkb:ISO_13485
|
|
gptkbp:collaborations
|
Healthcare organizations
Universities
Research institutes
|
|
gptkbp:employees
|
50-100
|
|
gptkbp:financial_products
|
Private company
Revenue growth
Funding rounds
Investment in R& D
Venture capital backing
|
|
gptkbp:focus
|
gptkb:Research_and_development
|
|
gptkbp:founded
|
gptkb:1997
|
|
gptkbp:founder
|
gptkb:Dr._John_D._Dyer
|
|
gptkbp:headquarters
|
gptkb:Europe
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Trevigen Europe
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:location
|
gptkb:government_agency
gptkb:Italy
gptkb:Monarch
gptkb:Spain
gptkb:United_Kingdom
|
|
gptkbp:parent_company
|
gptkb:Trevigen,_Inc.
|
|
gptkbp:partnerships
|
Industry partnerships
Research collaborations
|
|
gptkbp:products
|
Reagents
Cell culture products
Assay kits
|
|
gptkbp:research_focus
|
Cancer research
Cell biology
Toxicology
Drug discovery
Stem cell research
|
|
gptkbp:services
|
Technical support
Custom assay development
|
|
gptkbp:social_responsibility
|
gptkb:Community_engagement
gptkb:Sustainability_initiatives
Diversity and inclusion initiatives
Educational outreach
Employee volunteer programs
|
|
gptkbp:target_market
|
Academic institutions
Pharmaceutical companies
Biotechnology firms
|
|
gptkbp:trademark
|
gptkb:Trevigen®
gptkb:Trevigen_Assays®
gptkb:Trevigen_Cell_Culture®
gptkb:Trevigen_Reagents®
|
|
gptkbp:website
|
www.trevigen.com
|